Pharmaxis Ltd reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported revenue was AUD 8.08 million compared to AUD 5.89 million a year ago. Net income was AUD 0.943 million compared to net loss of AUD 3.03 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 AUD | -4.00% |
|
-17.24% | +20.00% |
Jun. 13 | Transcript : Syntara Limited Presents at MST Access 'Hidden Gems in Life Sciences' Webinar, Jun-13-2024 02:30 PM | |
Apr. 30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 19.8M | |
+52.70% | 796B | |
+41.58% | 628B | |
-4.86% | 358B | |
+21.96% | 331B | |
+11.47% | 301B | |
+17.72% | 244B | |
+4.46% | 228B | |
+13.13% | 214B | |
+10.46% | 165B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Pharmaxis Ltd Reports Earnings Results for the First Quarter Ended September 30, 2022